June 25, 2007 - Princess Margaret Hospital (PMH) breast cancer specialists in Toronto, Canada, are now using a new way to treat patients by delivering a one-time dose of radiation during surgery called intraoperative radiation therapy that takes less than one hour and reportedly eliminates the need for further radiation treatments.

“The potential benefits to patients are huge,” says lead surgeon Dr. David McCready, who also heads the PMH Breast Cancer Program. “Treating the specific area of cancer with this kind of precision protects the skin, heart and lungs from unnecessary radiation, minimizes side effects, and saves the patient a lot of time.”

The system works by using a probe attached to the portable intrabeam radiotherapy machine, a single, concentrated dose is then inserted directly into the affected area inside the breast during surgery. Dr. McCready says the one-time dose is “biologically equivalent” to conventional radiation treatments for breast cancer that typically require, on average, a minimum of 16 treatments over three weeks.

Dr. Anthony Fyles, the radiation oncologist who leads the Breast Radiation Oncology Program and treated the first patient in the operating room that day, says: “This procedure is helping us understand more about the biology of how breast tissue responds to treatment. That knowledge, in turn, will help us further customize and select the best treatment options for individuals with early breast cancer.”

For more information: www.uhn.ca


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now